T cell immunoglobulin domain and mucin domain-3 as an emerging target for immunotherapy in cancer management

Overview of attention for article published in ImmunoTargets and Therapy, November 2013

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (78th percentile)

Mentioned by

twitter: 1 X user

patent: 2 patents

Citations

dimensions_citation: 9 Dimensions

Readers on

mendeley: 18 Mendeley

Summary X Patents Dimensions citations

So far, Dimensions has found 9 publications that cite this research output.

9

The most recent citing publications are shown below. View all 9 publications that cite this research output on Dimensions.

Immune checkpoint inhibitors in the treatment of hepatocellular carcinoma

Article in Frontiers in Immunology (April 2024)

Immunotherapeutic Approaches for the Treatment of Glioblastoma Multiforme: Mechanism and Clinical Applications

Article in International Journal of Molecular Sciences (June 2023)

Prominent Targets for Cancer Care: Immunotherapy Perspective

Article in Current Cancer Therapy Reviews (January 2023)